Comparing two therapies for people with OCD
Comparing Exposure v Imagery Rescripting in People With Obsessive Compulsive Disorder (OCD): a Single Case Experimental Design (SCED)
This study is testing whether imagery rescripting or exposure therapy works better to help people with OCD who have troubling thoughts and images feel better in their daily lives.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 10 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | King's College London Academic / other |
| Locations | 1 site (London) |
| Trial ID | NCT06944366 on ClinicalTrials.gov |
What this trial studies
This project investigates the effectiveness of two therapeutic approaches, imagery rescripting and exposure therapy, for individuals suffering from obsessive-compulsive disorder (OCD) who experience distressing future-oriented thoughts and images. Participants will be assessed for their suitability based on specific criteria, including the presence of ego-dystonic images. The study aims to determine which intervention may provide better relief from symptoms and improve overall functioning in daily life.
Who should consider this trial
Good fit: Ideal candidates are adults aged 18 and over with a primary diagnosis of OCD who experience distressing future-oriented images.
Not a fit: Patients with psychosis, bipolar disorder, or those currently engaged in other psychotherapy may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could lead to more effective treatment options for individuals with OCD, enhancing their quality of life.
How similar studies have performed: While there is existing research on both imagery rescripting and exposure therapy, this specific comparison in the context of OCD is relatively novel.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * 18 years or over * Main diagnosis of OCD (assessed by the Structured Clinical Interview for ICD11) * Must report future orientated images that are distressing and ego-dystonic Exclusion Criteria: * Psychosis, bipolar disorder, or trauma disorder * Current stimulant or hallucinogenic misuse, alcohol or substance misuse or dependence * Intellectual disability, dementia, serious cognitive impairment, or organic brain disorder * Personality Disorder as the main problem * Active suicidality * Concurrent engagement in other psychotherapy * A patient may be taking anti-depressant medication so long as the dose has been stable for 6 weeks and there is no plan to increase the dose.
Where this trial is running
London
- Centre for Anxiety Disorders and Trauma — London, United Kingdom (Recruiting)
Study contacts
- Study coordinator: Talana Adams
- Email: talana.e.adams@kcl.ac.uk
- Phone: +44 20 7848 0002
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.